Mohamed Salah

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Topics

Estrogen Receptor

Pluripotent Stem Cells

Top Venues

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Mohamed Salah, Mariam Tahoun, Jeannette Rudzitis-Auth, Lisa Stotz, Chris J van Koppen, Matthias W Laschke, Ahmed S Abdelsamie, Martin Frotscher
Potent Dual Inhibitors of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 with a Suitable Pharmacokinetic Profile for In Vivo Proof-of-Principle Studies in an Endometriosis Mouse Model. Journal of medicinal chemistry (2023)
Ahmed S Abdelsamie, Mohamed Salah, Lorenz Siebenbürger, Ahmed Merabet, Claudia Scheuer, Martin Frotscher, Sebastian T Müller, Oliver Zierau, Günter Vollmer, Michael D Menger, Matthias W Laschke, Chris J van Koppen, Sandrine Marchais-Oberwinkler, Rolf Wolfgang Hartmann
Design, Synthesis, and Biological Characterization of Orally Active 17β-Hydroxysteroid Dehydrogenase Type 2 Inhibitors Targeting the Prevention of Osteoporosis. Journal of medicinal chemistry 62 (15) (2019)
Ahmed S Abdelsamie, Steven Herath, Yannik Biskupek, Carsten Börger, Lorenz Siebenbürger, Mohamed Salah, Claudia Scheuer, Sandrine Marchais-Oberwinkler, Martin Frotscher, Tim Pohlemann, Michael D Menger, Rolf Wolfgang Hartmann, Matthias W Laschke, Chris J van Koppen
Targeted Endocrine Therapy: Design, Synthesis, and Proof-of-Principle of 17β-Hydroxysteroid Dehydrogenase Type 2 Inhibitors in Bone Fracture Healing. Journal of medicinal chemistry 62 (3) (2019)
Mohamed Salah, Mohammad Abdel-Halim, Matthias Engel
Design and synthesis of conformationally constraint Dyrk1A inhibitors by creating an intramolecular H-bond involving a benzothiazole core. MedChemComm 9 (6) (2018)